Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Department of Biochemistry and Molecular Pharmacology, Perlmutter NYU Cancer Center, New York University Grossman School of Medicine, and Howard Hughes Medical Institute, The Alexandria Center of Life Science, East Tower, 450 E, 29th Street, New York, NY 10016, USA.
J Mol Biol. 2021 Mar 5;433(5):166795. doi: 10.1016/j.jmb.2020.166795. Epub 2021 Jan 7.
The SCF ubiquitin ligase relieves G1 checkpoint control of CDK-cyclin complexes by promoting p27KIP1 degradation. We describe reconstitution of stable complexes containing SKP1-SKP2 and CDK1-cyclin B or CDK2-cyclin A/E, mediated by the CDK regulatory subunit CKS1. We further show that a direct interaction between a SKP2 N-terminal motif and cyclin A can stabilize SKP1-SKP2-CDK2-cyclin A complexes in the absence of CKS1. We identify the SKP2 binding site on cyclin A and demonstrate the site is not present in cyclin B or cyclin E. This site is distinct from but overlapping with features that mediate binding of p27KIP1 and other G1 cyclin regulators to cyclin A. We propose that the capacity of SKP2 to engage with CDK2-cyclin A by more than one structural mechanism provides a way to fine tune the degradation of p27KIP1 and distinguishes cyclin A from other G1 cyclins to ensure orderly cell cycle progression.
SCF 泛素连接酶通过促进 p27KIP1 的降解来解除 CDK-周期蛋白复合物的 G1 检验点控制。我们描述了由 CDK 调节亚基 CKS1 介导的包含 SKP1-SKP2 和 CDK1-周期蛋白 B 或 CDK2-周期蛋白 A/E 的稳定复合物的重建。我们进一步表明,SKP2 N 端基序与细胞周期蛋白 A 之间的直接相互作用可以在没有 CKS1 的情况下稳定 SKP1-SKP2-CDK2-细胞周期蛋白 A 复合物。我们确定了细胞周期蛋白 A 上的 SKP2 结合位点,并证明该位点不存在于细胞周期蛋白 B 或细胞周期蛋白 E 中。该位点与介导 p27KIP1 和其他 G1 周期蛋白调节剂与细胞周期蛋白 A 结合的特征既不同又重叠。我们提出,SKP2 通过不止一种结构机制与 CDK2-细胞周期蛋白 A 结合的能力提供了一种微调 p27KIP1 降解的方法,并将细胞周期蛋白 A 与其他 G1 细胞周期蛋白区分开来,以确保细胞周期的有序进行。